How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

762 results for

Interview Questions for the Physician Candidate

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. EPC Pilot Project: A Dual Approach To Facilitate Health Systems Uptake of Evidence Synthesis Reports. Anxiety in Children

and asked about four issues: 1. Awareness of EPC evidence synthesis products and prior use for decision-making 2. Usefulness of the tool in terms of supporting decision-making process. 3. Need for additional contextual information required for decision-making. 4. Generalizability of this tool/approach to other topic areas. The questions used with health system stakeholders and patients/clinicians are listed below: Health System Decision Aid Interview Questions 1. Are you aware of EPC evidence synthesis (...) a published evidence report on anxiety in children. We conducted a non- systematic review of Pubmed, searched the Internet and interviewed experts and other stakeholders for literature on factors essential for treatment decision-making. Methods. We followed a dual approach in which we developed two tools, one for the health system (based on the Evidence to Decision Framework) and the second for the clinical encounter (a shared decision-making tool). The tools provided contextual and implementation

2018 Effective Health Care Program (AHRQ)

122. CAEP FEI | Human Trafficking Awareness: A Learning Module

are trained to recognize child abuse and intimate partner violence, there is no routine education regarding identifying trafficking victims. 5 A study in the United States interviewed trafficking victims in shelters where they learned that in addition to not being identified as needing help, the victims reported being hurt and humiliated by physicians during their encounter in the emergency room. 3 Simple training modules, some as short as 20 minutes, have been shown to have a significant impact (...) CAEP FEI | Human Trafficking Awareness: A Learning Module CAEP FEI | Human Trafficking Awareness: A Learning Module - CanadiEM CAEP FEI | Human Trafficking Awareness: A Learning Module In , by Julianna Deutscher September 21, 2018 Jeremy is a second year resident who is about to see a 25 year old female presenting with abdominal pain. During the history he notices the patient is remarkably quiet and that the patient’s male friend is answering all the questions for her. When Jeremy asks the male

2018 CandiEM

123. Management of Pregnancy

. Nutrition 39 c. Screening 40 d. Education 43 B. One-time Interventions 44 a. Screening and Diagnostic Testing 44 b. Imaging 49 c. Preparing for Delivery 50 d. Postpartum Care 51 C. Referral 52 D. Special Considerations 55 a. High Risk for Preeclampsia 55 b. High Risk for Preterm Delivery 56 c. Over 44 Years of Age 57 d. History of Bariatric Surgery 58 Appendix A: Evidence Review Methodology 62 A. Developing the Scope and Key Questions 62 a. Population(s) 62 b. Interventions 62 c. Comparators 64 d (...) . Outcomes 65 B. Conducting the Systematic Review 67 a. General Criteria for Inclusion in Systematic Review 69 b. Key Question Specific Criteria 70 c. Literature Search Strategy 71 C. Convening the Face-to-face Meeting 71 D. Grading Recommendations 72 E. Recommendation Categorization 75 a. Recommendation Categories and Definitions 75 b. Categorizing Recommendations with an Updated Review of the Evidence 76 c. Categorizing Recommendations without an Updated Review of the Evidence 77 F. Drafting

2018 VA/DoD Clinical Practice Guidelines

124. Lower Limb Prostheses: Measurement Instruments, Comparison of Component Effects by Subgroups, and Long-Term Outcomes

, Comparison of Component Effects by Subgroups, and Long-Term Outcomes Structured Abstract Background. Lower limb prosthesis (LLP) candidates are a heterogeneous group. Many LLP options exist. How to best match an amputee with an LLP is unclear. Optimal selection of devices should be guided by evidence on which amputees would do best with which LLP component or configuration, and which evaluation instruments are valid and reliable in this population. Methods. We addressed questions pertaining to: assessing (...) will be helpful to health plans, providers, purchasers, government programs, and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. If you have comments on this systematic review, they may be sent by mail to the Task Order Officers named below

2018 Effective Health Care Program (AHRQ)

125. Antiandrogen Therapies for Nonmetastatic Castration-Resistant Prostate Cancer: Effectiveness and Value

therapy has failed when PSA levels begin to rise leading some to question their prior decisions about therapy. In a 2017 survey report from the Cancer Support Community, 49 patients rated the following factors to be among the “most important” considerations when selecting a treatment for their prostate cancer: higher chance for survival (27%), higher chance for cure (20%), recommendations from a doctor (16%), and fewer side effects (14%). 17 In our discussions with patient groups, we heard (...) with CRPC and how this affects men and their families, the psychological effects of prostate cancer on a man’s sense of self, the substantial side effects of therapies for prostate cancer, and the sense that burdensome therapy has failed when PSA levels begin to rise leading some to question their prior decisions about therapy. In a 2017 survey report from the Cancer Support Community, 49 patients rated the following factors to be among the “most important” considerations when selecting a treatment

2018 California Technology Assessment Forum

126. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

contents of this report or should be assumed to support any part of this report, which is solely the work of the ICER team and its affiliated researchers. For a complete list of stakeholders from whom we requested input, please visit: https://icer-review.org/material/psoriasis-stakeholder-list/ Expert Reviewers Alexa B. Kimball, MD Harvard Medical Faculty Physicians Beth Israel Deaconess Medical Center Conflict of Interest Declaration: Alexa B. Kimball is a consultant for Novartis, AbbVie, UCB, Lilly (...) Institute for Clinical and Economic Review, 2018 Page ES4 Final Evidence Report: Plaque Psoriasis Condition Update Return to Table of Contents For many of these agents, there is some suggestion of waning effectiveness with continued use, known as biologic fatigue. 21 To maintain effectiveness, physicians often prescribe increasing doses of targeted immunomodulators. On the other hand, physicians occasionally prescribe lower doses of effective medications to decrease out-of-pocket costs. Patients

2018 California Technology Assessment Forum

127. Enhancing Equitable Access to Assistive Technologies in Canada

) questions or prompts about the need for assistive technologies in decision aids that support care planning and purchasing; and 3) providing system navigators for those with complex needs. o The use of decision-aids and provision of education in the delivery of care was generally found to have positive effects, including improved knowledge, reduced levels of anxiety and increased adherence to treatments, for patients and caregivers. While evidence on system navigators is limited, they were found (...) brief summarizes research evidence drawn from systematic reviews of the research literature and occasionally from single research studies. A systematic review is a summary of studies addressing a clearly formulated question that uses systematic and explicit methods to identify, select and appraise research studies, and to synthesize data from the included studies. The evidence brief does not contain recommendations, which would have required the authors of the brief to make judgments based

2017 McMaster Health Forum

128. Identifying and Assessing Core Components of Collaborative-care Models for Treating Mental and Physical Health Conditions

and diagnosis of mental illness and associated symptoms; and supporting physicians in the prescription of pharmacotherapy for depression and anxiety disorders.(8; 29; 31; 35; 45; 46) Further details related to training of providers is summarized in question four below. Other additional intervention components that were identified in our review included communication technology, such as shared medical Identifying and Assessing Core Components of Collaborative-care Models for Treating Mental and Physical (...) -considered actions, and communicate the rationale for actions effectively. Authors Heather L. Bullock, PhD candidate, Co-Lead, Evidence Synthesis, McMaster Health Forum, McMaster University Kerry Waddell, M.Sc., Co-Lead, Evidence Synthesis, McMaster Health Forum, McMaster University Michael G. Wilson, PhD, Assistant Director, McMaster Health Forum, and Assistant Professor, McMaster University Funding This knowledge synthesis was funded by: 1) Trillium Health Partners through funds received from

2017 McMaster Health Forum

129. Identifying the Effects of Using Telecommunications Technology to Provide Clinical Care at a Distance

of regular hospital visits or regular visits at home by primary-care providers, or visits to the family physician. Four of the five studies 2009 6/10 (AMSTAR rating from McMaster Health Forum) 0/12 17 Question Focus of systematic review Key findings Year of last search/ publication date AMSTAR (quality) rating Proportion of studies that were conducted in Canada included patients with diabetes, and found that the intervention group demonstrated improved health outcomes, especially a reduction in HbA1c (...) numbers ISSN 2292-7999 (online)McMaster Health Forum 3 Evidence >> Insight >> Action KEY MESSAGES Question • What are the effects of using telecommunications technology to provide clinical care at a distance on health outcomes, patient and provider satisfaction, and costs? Why the issue is important • A number of current pressures on the health system (e.g., an aging population, increased prevalence of chronic and co-morbid conditions) and increased focus on supporting patient self-management

2017 McMaster Health Forum

130. A Framework for Conceptualizing Evidence Needs of Health Systems

through interviews with health system stakeholders. Literature Search Eligible publications summarize original data or present reviews, commentaries and opinion pieces that describe the research evidence needs of health systems. We defined a health system as at least one hospital and one group of physicians; or two or more health care provider organizations with common ownership, contractual integration (e.g., accountable care organizations) or formal referral arrangements. Eligible publications (...) , succinct and easily understood evidence syntheses with layered information presentations. Studies of tools for promoting health system use of evidence describe methods for clarifying how the evidence applies to the local and operational context and how evidence intersects with other considerations in decisionmaking. Data from the four evidence synthesis programs illustrate a breadth of questions addressed and report types used by health systems. Discussions with health system experts highlighted

2018 Effective Health Care Program (AHRQ)

131. Calcitonin Gene-Related Peptide (CGRP) Inhibitors as Preventive Treatments for Patients with Episodic or Chronic Migraine: Effectiveness and Value

preventive therapy, those who have four or more days with headaches per month with some impairment may be considered candidates for preventive therapy. 1 Effective preventive pharmacologic therapies include some antidepressants (amitriptyline, venlafaxine), anti-seizure medications (divalproex sodium, sodium valproate, topiramate), and beta-blockers (propranolol, metoprolol). 16 Patients with chronic migraine may also use onabotulinum toxin A (Botox®, Allergan plc) injections for prevention. 17 Patients (...) interventions can be as debilitating as migraine. Patients struggle to access effective care or treatment: • Difficulties arise in finding a physician who understands migraine and migraine pain. • Due to high costs and access restrictions, patients may not have a sufficient supply of acute treatment (e.g., triptans); patients may ration treatment and choose the “important” days to take treatment. • Patients feel discouraged because treatment strategies follow a “guess and test” procedure, which can take

2018 California Technology Assessment Forum

132. Alcoholic Liver Disease

AH should preferably be hospitalized for management Treatment of alcoholic hepatitis 11. Severe AH is identi? ed by Maddrey’s discriminant function score >32 or MELD score >20 12. Systemic in? ammatory response syndrome (SIRS) at admission predisposes to acute kidney injury and multi-organ failure, which are associated with a poor prognosis. Physicians should take appropriate measures to prevent renal injury, such as avoidance of nephrotoxic drugs, judicious use of diuretics, and low threshold (...) >0.45 15. Patients non-responsive to corticosteroids, ineligible for early LT, and with multiple organ failures, may be considered for palliative therapy Liver transplantation in alcoholic liver disease Liver transplantation for alcoholic cirrhosis 16. Physicians should consider LT while formulating a management plan for patients with end-stage ALD 17. The decision on LT evaluation should not be based solely on minimum 6 months of alcohol abstinence, and other criteria should be taken into con

2018 American College of Gastroenterology

133. Clinical Consensus Statement: Balloon Dilation of the Sinuses Full Text available with Trip Pro

obstruction, to even obstructive sleep apnea. A recent review of balloon use by physicians within the Department of Defense health care system also indicated that SOD is often used for indications for which there is currently no evidence of efficacy. Furthermore, between 2011 and 2014, the number of balloon SOD procedures increased in excess of the drop in nonballoon procedures. This rise in SOD procedures, without a commensurate reduction in traditional functional endoscopic sinus surgery, has caused (...) increased scrutiny by payers and providers, which is further intensified by concern over potential inappropriate use of the procedure. Given the knowledge gap that exists regarding the role of SOD in managing CRS and the increasing rates of utilization, the Physician Payment Policy Working Group (3P) of the American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) submitted SOD to the AAO-HNS Foundation (AAO-HNSF) Guideline Task Force as a potential topic for a clinical practice guideline. Due

2018 American Academy of Otolaryngology - Head and Neck Surgery

134. Communicating Risk in Public Health Emergencies. A WHO Guideline for Emergency Risk Communication (ERC) policy and practice

32 7.2. Composition of guideline groups 34 7.3. Guideline Development Group 34 Plans for disseminating and evaluating the impact of these recommendations 37 8.1. Monitoring and evaluation 38 8.2. Review by date 38 1. 2. 3. 4. 5. 6. 7. 8.iv a WHO guideline for emergency risk communication (ERC) policy and practice References 39 Annexes 43 Annex 1. Composition of guideline groups 43 Annex 2. Guideline development methods 46 Annex 3. SPICE questions 53 List of tables T able 1. WHO guidance on risk (...) communication 4 T able 2. Questions to guide evidence reviews 5 T able 3. Methods used to improve community engagement 15 T able 4. Data gathering tools 27 T able 5. Research priorities and gaps 32 T able 6. Internal Steering Group members 43 T able 7. Guideline Development Group members 44 T able 8. External Review Group members 45 List of figures Figure 1. Summary of methods reviewers used to develop the evidence synthesis 6v a WHO guideline for emergency risk communication (ERC) policy and practice

2018 World Health Organisation Guidelines

135. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Risks

-00010-I Prepared by: RAND Southern California Evidence-based Practice Center Santa Monica, CA Investigators: Sydne J. Newberry, Ph.D. Mei Chung, M.P.H., Ph.D. Cheryl A.M. Anderson, Ph.D., M.P.H., M.S. Christine Chen, M.D., M.P.H., Ph.D. candidate Zhuxuan Fu, M.P.H. Alice Tang, Ph.D., Sc.M. Naisi Zhao, M.H.S., Dr.Ph candidate Marika Booth, M.S. Joyce Marks, B.S. Simon Hollands, M.S., Ph.D. candidate Aneesa Motala, B.A. Jody Larkin, M.S. Roberta Shanman, M.L.S. Susanne Hempel, Ph.D. AHRQ Publication (...) , and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. We welcome comments on this systematic review. They may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD

2018 Effective Health Care Program (AHRQ)

136. Outcome Measures Framework: Information Model Report

. In this case, the registry participant is the mother, and the baby is actually not a participant. Hence, “Impact on Non-participant” is listed within the OMF as an outcome related to someone other than an enrollee. Similarly, patient experience of care is being evaluated with more frequency, but represents an outcome other than the end result of the patient’s treatment. Used to capture things like treatment satisfaction, waiting times, satisfaction with physician care, this category is intended

2018 Effective Health Care Program (AHRQ)

137. Clinical Practice Guideline for the Behavioral Treatment of Obesity and Overweight in Children and Adolescents

and Appointment of Members to the Obesity GDP 13 Conflicts of Interest 13 Scoping and Key Questions 14 Comprehensive Search of the Professional Literature 14 Development of Evidence Tables 18 Development and Use of the Grid 18 Decision-Making Regarding Treatment Recommendations 19 External Review Process 20 Recommendations and Statement of Evidence 21 Potential Harms and Burdens of Treatment 25 Potential Harms 25 Potential Burdens 25 Implementation 27 Discussion 29 Applicability of Results and Clinical (...) Procedures Established by Advisory Steering Committee 60CLINICAL PRACTICE GUIDELINE FOR MULTICOMPONENT BEHAVIORAL TREATMENT OF OBESITY AND OVERWEIGHT IN CHILDREN AND ADOLESCENTS 1 Introduction Over the past five decades, rates of childhood obesity have increased almost four-fold (Ogden, Carroll, Kit, & Flegal, 2014). Moreover, there are differences in prevalence rates by race (American Academy of Family Physicians, 2014; Ogden, Carroll, Fryar, & Flegal, 2015) and socioeconomic status (August et al., 2008

2018 American Psychological Association

138. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

of Cardiovascular MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT Grundy SM, et al. 2018 Cholesterol Clinical Practice Guidelines Page 2 and Pulmonary Rehabilitation, American Academy of Physician Assistants, Association of Black Cardiologists, American College of Preventive Medicine, American Diabetes Association, American Geriatrics Society, American Pharmacists Association, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association in October 2018 (...) of the Writing Committee The writing committee consisted of medical experts including cardiologists, internists, interventionalists, a nurse practitioner, pharmacists, a physician assistant, a pediatrician, a nephrologist, and a lay/patient representative. The writing committee included representatives from the American Heart Association (AHA), American College of Cardiology (ACC), American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), American Association Academy of Physician

2018 American College of Cardiology

139. Erectile Dysfunction

. Evidence strength refers to the body of evidence available for a particular question and includes not only individual study quality but consideration of study design; consistency of findings across studies; adequacy of sample sizes; and generalizability of samples, settings, and treatments for the purposes of the guideline. The American Urological Association (AUA) categorizes body of evidence strength as Grade A (well-conducted and highly-generalizable RCTs or exceptionally strong observational (...) /burdens of various management options. 11 This commitment also requires that the clinician be cognizant that social, cultural, religious, educational, and other factors are important and valid determinants of treatment selection. 12,13 The patient's commitment includes the willingness to absorb information, ask questions, and clearly express his and his partner's preferences and values. This process results in a sharing of information and responsibility, allowing a collaborative decision regarding

2018 American Urological Association

140. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

of this report or should be assumed to support any part of this report, which is solely the work of the ICER team and its affiliated researchers. For a complete list of stakeholders from whom we requested input, please visit: https://icer-review.org/material/psoriasis-stakeholder-list/ Expert Reviewers Alexa B. Kimball, MD Harvard Medical Faculty Physicians Beth Israel Deaconess Medical Center Conflict of Interest Declaration: Alexa B. Kimball is a consultant for Novartis, AbbVie, UCB, Lilly, Janssen (...) and Economic Review, 2018 Page ES4 Evidence Report: Targeted Immunomodulators for Plaque Psoriasis | Condition Update Return to Table of Contents For many of these agents, there is some suggestion of waning effectiveness with continued use, known as biologic fatigue. 21 To maintain effectiveness, physicians often prescribe increasing doses of targeted immunomodulators. On the other hand, physicians occasionally prescribe lower doses of effective medications to decrease out-of-pocket costs. Patients

2018 California Technology Assessment Forum

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>